Skip to main content

Table 1 Demographics of the study subjects

From: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study

Study Group

Number

Age (yr) Median (range)

Sex (male: female)

Race

ASD1

    

Test

26

7.6 (2.3–13.4)

25:1

W2 24, H 1, AA 0, A 1

Control

107

4.8 (1.5–17.3)

92:15

W 77, H 7, AA 11, A 9, other 3

CRS/ROM

38

6.8 (1.0–17.8)

27:11

W 12, H 16, AA 8, A 2

FA

24

2.5 (1.0–13.7)

18:6

W 12, H 4, AA 4, A 4

Control

43

7.0 (1.0–13.8)

31:12

W 31, H 6, AA 3, A 3

  1. 1 ASD test group patients were diagnosed with autism (N = 21), pervasive developmental disorder not otherwise specified (PDD-NOS) (N = 4), and ASD (not categorized as autism or PDD-NOS due to age) (N = 1). ASD control group patients were diagnosed with autism (N = 70), PDD-NOS (N = 27), and ASD (not categorized as autism or PDD-NOS due to age) (N = 10).
  2. 2 Abbreviations: W Caucasian, H Hispanic, AA African American, A Asian.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094